Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Accumulated Expenses (2016 - 2021)

Historic Accumulated Expenses for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to $2.1 million.

  • Phio Pharmaceuticals' Accumulated Expenses rose 4989.09% to $2.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.1 million, marking a year-over-year increase of 4989.09%. This contributed to the annual value of $1.4 million for FY2020, which is 4024.9% up from last year.
  • According to the latest figures from Q3 2021, Phio Pharmaceuticals' Accumulated Expenses is $2.1 million, which was up 4989.09% from $2.1 million recorded in Q2 2021.
  • In the past 5 years, Phio Pharmaceuticals' Accumulated Expenses ranged from a high of $2.2 million in Q2 2018 and a low of $703000.0 during Q1 2019
  • For the 5-year period, Phio Pharmaceuticals' Accumulated Expenses averaged around $1.5 million, with its median value being $1.5 million (2021).
  • In the last 5 years, Phio Pharmaceuticals' Accumulated Expenses soared by 6946.81% in 2017 and then tumbled by 6488.51% in 2019.
  • Over the past 5 years, Phio Pharmaceuticals' Accumulated Expenses (Quarter) stood at $1.8 million in 2017, then crashed by 31.93% to $1.2 million in 2018, then dropped by 19.26% to $964000.0 in 2019, then soared by 40.25% to $1.4 million in 2020, then skyrocketed by 52.44% to $2.1 million in 2021.
  • Its Accumulated Expenses was $2.1 million in Q3 2021, compared to $2.1 million in Q2 2021 and $1.5 million in Q1 2021.